z-logo
open-access-imgOpen Access
Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time?
Author(s) -
Thomas A. Hope,
Marianne Pavel,
Emily K. Bergsland
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.22.00176
Subject(s) - radionuclide therapy , medicine , neuroendocrine tumors , peptide receptor , dosing , biomarker , oncology , somatostatin receptor , somatostatin , receptor , biochemistry , chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom